Momenta Pharmaceuticals, Inc. (MNTA)

[vinmantoo]

{{ There is no imminent upside for MNTA now, making it a good timing for short term investors to exit. MNTA now has ~1.7B market cap it is certainly not cheap.}}

I have exactly the opposite view. There upside for MNTA is more imminent and higher than ever. If the legal issue regarding mEnox and safe harbor is decided in MNTA's favor, longs will benefit. If not, that has already be priced in. Money from Glatopa 2omg formulation will start accruing, and the 40mg ANDA has been accepted. The approval of Glatopa also raises the profile for MNTA for their Biosimilar antibody program. Necuparanib is now in a phase II pancreatic cancer trial after showing encouraging phase I data.

When you add that up, it sounds pretty good to me now, and for the near future.